摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

D-Ala-Gly-OBzl*HCl | 64410-45-3

中文名称
——
中文别名
——
英文名称
D-Ala-Gly-OBzl*HCl
英文别名
H-(D)Ala-Gly-OBzl.hydrochloride;benzyl 2-[[(2R)-2-aminopropanoyl]amino]acetate;hydrochloride
D-Ala-Gly-OBzl*HCl化学式
CAS
64410-45-3
化学式
C12H16N2O3*ClH
mdl
——
分子量
272.732
InChiKey
OEHNLEPORPSQBG-SBSPUUFOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.61
  • 重原子数:
    18
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    81.4
  • 氢给体数:
    3
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    D-Ala-Gly-OBzl*HCl 在 palladium on activated charcoal 氢气1-羟基苯并三唑三乙胺N,N'-二环己基碳二亚胺 作用下, 以 甲醇溶剂黄146N,N-二甲基甲酰胺 为溶剂, 25.0 ℃ 、275.79 kPa 条件下, 反应 124.0h, 生成 Boc-酪氨酸-D-丙氨酸-甘氨酸
    参考文献:
    名称:
    Novel analogs of enkephalin: identification of functional groups required for biological activity
    摘要:
    Novel tri- and tetrapeptide analogues of enkephalin, in conjunction with earlier structure-activity data, confirm that chemical substitutents present in the first and fourth residues of enkephalin are required for in vitro biological activity. A class of arylamino and alkylamino derivatized tripeptides also were found to have significant in vitro opioid-like activity indistinguishable from [D-Ala2,D-Leu5]enkephalin and morphine.
    DOI:
    10.1021/jm00184a010
  • 作为产物:
    描述:
    Boc-D-Ala-Gly-OBzl盐酸 作用下, 以 1,4-二氧六环 为溶剂, 反应 3.0h, 以100%的产率得到D-Ala-Gly-OBzl*HCl
    参考文献:
    名称:
    Novel analogs of enkephalin: identification of functional groups required for biological activity
    摘要:
    Novel tri- and tetrapeptide analogues of enkephalin, in conjunction with earlier structure-activity data, confirm that chemical substitutents present in the first and fourth residues of enkephalin are required for in vitro biological activity. A class of arylamino and alkylamino derivatized tripeptides also were found to have significant in vitro opioid-like activity indistinguishable from [D-Ala2,D-Leu5]enkephalin and morphine.
    DOI:
    10.1021/jm00184a010
点击查看最新优质反应信息

文献信息

  • Methods of preparing manganese complexes of nitrogen-containing
    申请人:Monsanto Company
    公开号:US05610293A1
    公开(公告)日:1997-03-11
    The present invention is directed to low molecular weight mimics of superoxide dismutase (SOD) represented by the formula: ##STR1## wherein R, R', R.sub.1, R'.sub.1, R.sub.2, R'.sub.2, R.sub.3, R'.sub.3, R.sub.4, R'.sub.4, R.sub.5, R'.sub.5, R.sub.6, R'.sub.6, R.sub.7, R'.sub.7, R.sub.8, R'.sub.8, R.sub.9, and R'.sub.9 and X, Y, Z and n are as defined herein, useful as therapeutic agents for inflammatory disease states and disorders, ischemic/reperfusion injury, stroke, atherosclerosis, hypertension and all other conditions of oxidant-induced tissue damage or injury.
    本发明涉及超化物歧化酶(SOD)的低分子量模拟物,其表示为以下式子:##STR1## 其中R,R',R1,R'1,R2,R'2,R3,R'3,R4,R'4,R5,R'5,R6,R'6,R7,R'7,R8,R'8,R9和R'9以及X,Y,Z和n如本文所定义,可用作治疗炎症性疾病状态和障碍,缺血/再灌注损伤,中风,动脉硬化,高血压以及所有其他化剂引起的组织损伤或损伤的治疗剂。
  • Organic compounds
    申请人:Sandoz Ltd.
    公开号:US04438103A1
    公开(公告)日:1984-03-20
    The invention provides polypeptides of formula I, A--B--Gly--D--E I wherein A is Tyr or substituted Tyr, B is --Gly-- or --(D)Ala--, D is, for example, Phe or MePhe and E is, for example, --Met--X, --Leu--X,--Nle--X, --Nva--X, --Ile--X, methioninesulphoxide--X, methioninesulphone--X wherein X is --NR'R" or --OR'" and each of R', R" and R'" independently signifies hydrogen or alkyl of 1 to 5 carbon atoms, which compounds possess pharmacological activity, for example, analgesic activity.
    本发明提供了公式I的多肽,A-B-Gly-D-E I其中A为酪氨酸或取代的酪氨酸,B为-Gly-或-(D)Ala-,D为例如酸或MePhe,而E为例如-Met-X,-Leu-X,-Nle-X,-Nva-X,-Ile-X,甲基亮酸-X,甲酰基亮酸-X,其中X为-NR'R"或-OR'",而R'、R"和R'"各自独立地表示1至5个原子的或烷基,这些化合物具有药理活性,例如镇痛活性。
  • Manganese complexes of nitrogen-containing macrocyclic ligands effective
    申请人:G. D. Searle & Co.
    公开号:US06084093A1
    公开(公告)日:2000-07-04
    The present invention is directed to low molecular weight mimics of superoxide dismutase (SOD) represented by the formula: ##STR1## wherein R, R', R.sub.1, R'.sub.1, R.sub.2, R'.sub.2, R.sub.3, R'.sub.3, R.sub.4, R'.sub.4, R.sub.5, R'.sub.5, R.sub.6, R'.sub.6, R.sub.7, R'.sub.7, R.sub.8, R'.sub.8, R.sub.9, and R'.sub.9 and X, Y, Z and n are as defined herein, useful as therapeutic agents for inflammatory disease states and disorders, ischemic/reperfusion injury, stroke, atherosclerosis, hypertension and all other conditions of oxidant-induced tissue damage or injury.
    本发明涉及超化物歧化酶(SOD)的低分子量模拟物,其化学式为:##STR1## 其中R,R',R1,R'1,R2,R'2,R3,R'3,R4,R'4,R5,R'5,R6,R'6,R7,R'7,R8,R'8,R9和R'9以及X,Y,Z和n的定义如本文所述,用作治疗炎症性疾病状态和疾病,缺血/再灌注损伤,中风,动脉粥样硬化,高血压以及所有化剂引起的组织损伤或损伤的情况下的治疗剂。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸